Stay updated on Faricimab in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.6.6 to v3.7.0, reflecting a new update to the study record's documentation. This change does not alter the study details or data accessible on the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated to v3.6.6, indicating a small, behind-the-scenes update to the page template or metadata.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded a new entry '2018 ( U.S. NIH Grant/Contract )' to the study's identifiers section, recording NIH funding associated with the trial. This update updates the funding disclosures reflected in the study's metadata.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's version details.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor version bump in the page's underlying documentation or tooling; no user-facing trial content or functionality appears to be altered.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3. This appears to be a minor update to the page’s metadata or content tracked in the site’s version history.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.